Skip to main content
Premium Trial:

Request an Annual Quote

ProteoGenix, Bruker to Develop Protein Biomarker Platform

NEW YORK, Sept. 29 (GenomeWeb News) - ProteoGenix and Bruker Daltonics have signed a pact to develop a high-throughput protein biomarker discovery and mass spectrometry-based multi-analyte assay platform, the firms said today.

 

Under the collaboration, ProteoGenix will implement its protein biomarker discovery methods on Bruker Daltonics' autoflex II TOF/TOF instrument. The partners said they plan to increase the speed, efficiency, and throughput of protein biomarker discovery methods by utilizing Bruker's magnetic bead-based ClinProt platform for automatic processing of serum samples and other body fluids.

 

They also will use Bruker's ClinProTools analysis, visualization, and statistical model building software for biomarker discovery and ProteinScape software for management of the data processing and archiving from protein biomarker discovery workflow.

 

Terms of the collaboration were not disclosed.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.